Pop On Veneers® Celebrates National Smile Day with $200 Off, 4 Free Gifts, and a Life-Changing Confidence Boost
NEW YORK, May 29, 2025 /PRNewswire/ -- A great smile is everything! In celebration of National Smile Day, Pop On Veneers®—the fastest-growing name in custom removable cosmetic veneers—is turning up the volume on self-confidence with an unbeatable offer: $200 off + mystery savings with code SMILE200, and 4 free gifts with your veneer purchase. With FSA/HSA eligibility and affordable payment plans as low as $29/month, transforming your smile has never been easier and more accessible.
Dubbed a "game changer" by customers across the country, Pop On Veneers is helping people say goodbye to the embarrassment of missing teeth, chipped teeth, and gaps—and hello to stress-free smile transformations. Having delivered over 250,000 smiles and a viral presence across Facebook, Instagram, TikTok, and YouTube, Pop On Veneers is quickly becoming America's favorite cosmetic smile solution.
"I finally have the smile of my dreams," shares one thrilled customer. "Pop On Veneers truly feels like the best gift I could've ever given myself. It's fast, it's pain free, and it's 100% custom-made for your smile"
Pop On Veneers are meticulously crafted to cover gaps, chips, missing teeth, or discoloration—without any drilling, waiting rooms, or awkward dental visits. Customers can visit Pop On or receive an easy-to-use at-home impression kit with clear step-by-step instructions and return their molds using a prepaid label to Pop On's flagship location in New York City. Expert technicians then design precise, natural-looking removable veneers using cutting-edge technology combined with handcrafted detail. Thanks to a rush service option, customers can receive their custom veneers in as little as one week, making it easier than ever to start smiling with confidence.
When customers receive their veneers and first pop them on, the excitement is overwhelming—many are moved to tears as they see their new smile instantly transformed. The joy and amazement captured in countless stories show just how life-changing that first moment truly is. It's not just a smile; it's a whole new sense of confidence and happiness that lights up your world.
Pop On Veneers customers have been raving:
"You don't have to live with dental shame. Two weeks, no drilling, no pain—just you and a beautiful smile. You can't beat that!" says Black Ink Crew star and Pop On customer Spyder. "I can eat, I can talk, I can sing, I can do whatever I want" says Richard.
Customers also get to choose from three polished shades:
Hollywood White – bright, bold, and camera ready
Natural White – fresh, subtle and perfect for everyday wear
Mature Tan – warm, sophisticated, and and ideal for a more elegant smile
To take advantage of the $200 off + mystery savings Smile Day celebration, visit PopOnVeneers.com and use code SMILE200 at checkout.
Media Contact:
Pop On Veneers® PR Team
pr@poponveneers.com
www.poponveneers.com
New York, NY
View original content to download multimedia:https://www.prnewswire.com/news-releases/pop-on-veneers-celebrates-national-smile-day-with-200-off-4-free-gifts-and-a-life-changing-confidence-boost-302468783.html
SOURCE Pop On Veneers
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
CEOs of The LYCRA Company and Qore ® Join Global Fashion Summit Lineup
WILMINGTON, Del.--(BUSINESS WIRE)-- The LYCRA Company, a global leader in developing sustainable fibers and solutions for the apparel industry, announced today that its CEO, Gary Smith, is a speaker at the Global Fashion Summit: Copenhagen Edition 2025. He will be joined on stage by Jon Veldhouse, CEO of Qore ®, the maker of QIRA ®, a next-generation BDO and a key ingredient in bio-derived LYCRA ® fiber, which is launching later this year. The CEOs of The LYCRA Company and Qore® will discuss the development of bio-derived LYCRA® fiber made with QIRA®, made from annually renewable field corn, during their Fireside Chat at the Global Fashion Summit: From Farm to Fashion. Share Smith and Veldhouse will discuss the development of this sustainable fiber made from annually renewable field corn during their Fireside Chat: From Farm to Fashion. Their session takes place on Wednesday, June 4, at 3:35 CEST in the DR Concert Hall. The discussion will be moderated by Amy Nguyen, a researcher, writer, and founder of Sustainable & Social. This is the first time both companies are participating in the Global Fashion Summit, a premier platform focused on sustainability in the fashion industry. The companies have a prominent exhibit space for attendees to learn more about bio-derived LYCRA ® fiber made with QIRA ®. Here, visitors can be transported to the Qore ® site and cornfields in Iowa through a virtual reality experience. Bio-derived LYCRA ® EcoMade fiber will be the world's first large-scale, commercially available renewable elastane. It delivers equivalent performance to the original LYCRA ® fiber and serves as a one-to-one replacement with no re-engineering of fabrics, processes, or garment patterns required. The product contains 70 percent renewable content and can potentially reduce the carbon footprint of LYCRA ® fiber by up to 44 percent*. The LYCRA Company holds patents related to this renewable fiber in several regions including Europe. 'We're proud to join the Global Fashion Summit for the first time and showcase how collaboration can accelerate a more sustainable future for fashion,' said Gary Smith, CEO of The LYCRA Company. 'Partnering with Qore ® has enabled us to scale innovation that is renewable and ready to meet the demands of global fashion brands striving to meet their sustainability goals.' The newly constructed Qore ® site in Eddyville, Iowa, began operating last month and has started producing QIRA ®. The company will host a grand opening celebration in July. 'Starting production at our new state-of-the-art facility marks a major step forward—not just for Qore ®, but for the entire industry,' said Jon Veldhouse, CEO of Qore ®. 'With QIRA ® now being made in Iowa from annually renewable field corn, we're turning sustainable innovation into reality and helping our partners bring next-generation materials to market.' Learn more about this renewable offering by visiting *Estimate from Cradle-to-Gate Screening LCA for a representative LYCRA ® fiber manufacturing facility, June 2022, prepared by Ramboll Americas Engineering Solutions, Inc. About The LYCRA Company The LYCRA Company is a leading global fiber and technology solutions provider to the apparel and personal care industries committed to offering sustainable products using renewable, pre-, and post-consumer recycled ingredients that reduce waste and help set the stage for circularity. Headquartered in Wilmington, Delaware, United States, it owns the LYCRA ®, LYCRA HyFit ®, LYCRA ® T400 ®, COOLMAX ®, THERMOLITE ®, ELASPAN ®, SUPPLEX ® and TACTEL ® brands. The LYCRA Company adds value to its customers' products by offering unique innovations that meet the consumer's need for comfort and lasting performance. Learn more at About Qore ® LLC Formed through a joint venture by Cargill and HELM AG, Qore ® helps leading brands replace fossil-based chemistries with bio-derived intermediates. At the heart of the joint venture is the production of QIRA ®, the next-generation bio-derived 1,4-butanediol (BDO). Made biologically through the fermentation of plant-based sugars, QIRA ® can save up to 86% of greenhouse gas emissions when replacing today's widely used chemical intermediates made from traditional fossil sources. Bio-derived QIRA ® can be used the same way as its fossil counterpart but with significantly better environmental performance. For more information and inquiries, visit About The Global Fashion Summit Global Fashion Summit is a leading international forum for sustainability in fashion, presented by Global Fashion Agenda (GFA). Convening major decision makers from across the world, the forum was first launched in 2009 and has become a nexus for agenda-setting discussions and presentations on the most critical environmental, social and ethical issues facing our industry and planet, all intended to spark urgent action and accelerate impact in the industry. Learn more at
New York Post
2 hours ago
- New York Post
Chicago news anchor Diane Pathieu's hero firefighter husband Nicholas Adamski dies after battling cancer
A Chicago TV news anchor's hero firefighter husband has died after years of battling stage 4 brain cancer. ABC 7 Chicago traffic anchor Diane Pathieu's husband, Nicholas 'Nick' Adamski, died 'peacefully' in hospice care on May 27, the outlet reported. He was 42 years old. Advertisement 4 Nick Adamski died after being diagnosed with stage 4 brain cancer in 2020. Facebook / Diane Pathieu ABC7 Adamski, a member of the Milwaukee Fire Department, had been diagnosed with stage 4 glioblastoma in December 2020 after suddenly collapsing just before Christmas. Pathieu shared a black-and-white photo of her husband announcing her death on Thursday in a touching post on Instagram. Advertisement 'My angel, Nicholas 'Nick' Adamski, has gained his wings. He was surrounded by love and peace. Firefighter. Husband. Advocate. Hero,' Pathieu wrote. 'Nick faced stage 4 glioblastoma brain cancer with unmatched courage, grace, and an unshakable belief in PMA—Positive Mental Attitude.' The Chicago news anchor said her husband will be remembered as a man who 'served others, uplifted everyone he met, and never stopped smiling—even through the hardest days.' 4 Adamski was the husband of ABC 7 Chicago traffic anchor Diane Pathieu. Facebook / Diane Pathieu ABC7 Advertisement 'Forever in our hearts. I love you for always sweetheart,' she wrote. 'Keep that PMA. Love hard. Help others. And never, ever give up, and as Nick would say 'peace and veggie grease.'' The post announcing her husband's death came days after Pathieu shared on X that she would be stepping away from work 'for a bit' to care for him. During his time as a Milwaukee firefighter, Adamski had earned the Medal of Valor for saving an infant from a fire, according to ABC 7. Advertisement 4 The Chicago news anchor said her husband will be remembered as a man who 'served others, uplifted everyone he met, and never stopped smiling—even through the hardest days.' American Brain Tumor Association However, his life changed when he was rushed to Lutheran General Hospital in 2020 after collapsing. His devastating cancer diagnosis came despite having no prior symptoms, and he was given slightly over a year to live. 'The only thing I remember is my right leg going up and shaking everything,' Adamski told ABC 7 in 2022. 'After that, I couldn't tell you anything.' 4 During his time as a Milwaukee firefighter, Adamski had earned the Medal of Valor for saving an infant from a fire. Facebook / Diane Pathieu ABC7 Adamski continued to defy the odds for years, becoming an advocate for hope through appearances on podcasts, television, and radio, where he spread his signature message of 'PMA: Positive Mental Attitude.' Following his death, the American Brain Tumor Association referenced Pathieu's Instagram tribute to him on their Facebook page. Advertisement 'We are deeply saddened by the passing of Nicholas 'Nick' Adamski, beloved husband of ABC7 Chicago's Diane Pathieu. A devoted firefighter, fierce advocate, and GBM warrior, Nick faced grade 4 glioblastoma with extraordinary courage, grace, and his signature PMA—Positive Mental Attitude,' the association wrote. 'Through every challenge, Nick never stopped smiling. He served others, inspired hope, and uplifted everyone around him. His legacy will live on in the hearts of all who knew him—and in the countless lives he touched. 'To Diane and all who loved him, the ABTA community stands with you in love and remembrance. As Nick would say: 'Peace and veggie grease.' Adamski is survived by Pathieu, his devoted parents, stepfather, loving in-laws, brother, two sisters-in-law, two cherished nieces, and a nephew, according to his obituary in the Milwaukee Journal Sentinel.
Business Wire
2 hours ago
- Business Wire
CARMAT Announces the First Commercial Implants of Its Aeson® Artificial Heart Outside the European Union
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the ' Company ' or ' CARMAT '), today announces the first implants of its Aeson® artificial heart in a commercial set-up, outside the European Union (EU). Two implants of Aeson® artificial heart were performed during the week commencing May 26, 2025 in Israel. The first one was carried out at Hadassah Ein Kerem Hospital in Jerusalem by a team led by Pr Offer Amir, Pr Rabea Asleh and Dr Amit Korach, respectively director of the Heart Institute, director of heart failure unit and director of the cardiac surgery department at Hadassah Medical Center. The second one was carried out at Sheba Medical Center in Ramat Gan (Tel Aviv), by a team led by Dr Jeff Morgan, Dr Leonid Sternik, Dr Alex Fardman and Dr Eyal Nachum, respectively head of mechanical support unit, director of cardiac surgery department, heart failure cardiologist and cardiac transplant surgeon. Those are the first Aeson® implants made in a commercial set-up outside the European Union. These implants bring to 5 the total number of countries 1 where commercial implants have been performed so far. They confirm the trust placed in the device by healthcare professionals, and the growing interest in the therapy. About CARMAT CARMAT is a French MedTech that designs, manufactures and markets the Aeson ® artificial heart. The Company's ambition is to make Aeson ® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world's first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson ® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson ® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson ® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States. Founded in 2008, CARMAT is based in the Paris region, with its head offices located in Vélizy-Villacoublay and its production site in Bois-d'Arcy. The Company can rely on the talent and expertise of a multidisciplinary team of circa 200 highly specialized people. CARMAT is listed on the Euronext Growth market in Paris (Ticker: ALCAR / ISIN code: FR0010907956). For more information, please go to and follow us on LinkedIn. Disclaimer This press release and the information it contains do not constitute an offer to sell or subscribe, nor a solicitation of an offer to buy or subscribe, for CARMAT shares in any country. This press release may contain forward-looking statements regarding the Company's objectives and outlook. These forward-looking statements are based on the current estimates and anticipations of the Company's management and are subject to risk factors and uncertainties, including those described in its Universal Registration Document filed with the French Financial Markets Authority (Autorité des marchés financiers) (the 'AMF') under number D.25-0345 (the ' 2024 Universal Registration Document '), available free of charge on the websites of CARMAT ( and the AMF ( Readers' attention is particularly drawn to the fact that the Company's current cash runway is limited to mid-June 2025 (excluding the flexible equity financing line entered into with IRIS, which was announced on March 27, 2025). The Company is also subject to other risks and uncertainties, such as its ability to implement its strategy, the pace of development of its production and sales, the pace and results of ongoing or planned clinical trials, technological evolution and competitive environment, regulatory changes, industrial risks, and all risks associated with the Company's growth management. The Company's forward-looking statements mentioned in this press release may not be achieved due to these elements or other risk factors and uncertainties, whether unknown or not considered material and specific by the Company as of today. Aeson® is an active implantable medical device commercially available in the European Union and other countries recognising the CE mark. The Aeson® total artificial heart is intended to replace the ventricles of the native heart and is indicated as a bridge to transplant in patients with end-stage biventricular heart failure (Intermacs classes 1-4) who cannot benefit from maximal medical therapy or a left ventricular assist device (LVAD) and who are likely to benefit from a heart transplant within 180 days of implantation. The decision to implant and the surgical procedure must be carried out by healthcare professionals trained by the manufacturer. The documentation (clinician's manual, patient's manual and alarm booklet) must be read carefully to learn about the characteristics of Aeson® and the information required for patient selection and proper use (contraindications, precautions, side effects) of Aeson®. In the United States, Aeson® is currently only available as part of a feasibility clinical trial approved by the Food & Drug Administration (FDA).
